Clinical efficacy of avatrombopag and recombinant human thrombopoietin in the treatment of chronic liver disease-associated severe thrombocytopenia: A real-world study

• मुख्य लेखकों: Yong-Shuai Wang (लेखक), Wei Wang (लेखक), Sai Zhang (लेखक), Shen-Yu Zhang (लेखक), Ai-Zong Shen (लेखक), Hua-Chuan Song (लेखक), Huan-Zhang Yao (लेखक), Rui-Peng Song (लेखक), Fan-Zheng Meng (लेखक), Lei Li (लेखक), Bjoern Nashan (लेखक), Ji-Zhou Wang (लेखक), Lian-Xin Liu (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Purpose: To investigate the clinical efficacy of avatrombopag, an oral thrombopoietin receptor agonist, versus subcutaneous recombinant human thrombopoietin (rh-TPO) in the treatment of severe thrombocytopenia (TCP) associated with chronic liver disease (CLD).Methods: Clinical data of 250 patients w...